Home - Products - Others - Other Targets - 7-Ethyl-10-Hydroxy-Camptothecin

7-Ethyl-10-Hydroxy-Camptothecin

CAS No. 119577-28-5

7-Ethyl-10-Hydroxy-Camptothecin( —— )

Catalog No. M22862 CAS No. 119577-28-5

7-Ethyl-10-Hydroxy-Camptothecin is a natural product isolated from Camptotheca acuminata Decne.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Ethyl-10-Hydroxy-Camptothecin
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Ethyl-10-Hydroxy-Camptothecin is a natural product isolated from Camptotheca acuminata Decne.
  • Description
    7-Ethyl-10-Hydroxy-Camptothecin is a natural product isolated from Camptotheca acuminata Decne.
  • In Vitro
    12-Ethyl-9-hydroxycamptothecin is a derivative of Camptothecin.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    119577-28-5
  • Formula Weight
    392.41
  • Molecular Formula
    C22H20N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (212.36 mM)
  • SMILES
    CCC1=C2C(=C(C=C1)O)C=C3CN4C(=CC5=C(C4=O)COC(=O)C5(CC)O)C3=N2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Methyl?Dihydrojasmon...

    Methyl dihydrojasmonate is an ester and a diffusive aroma compound, with the smell vaguely similar to jasmine.

  • NH2-C4-NH-Boc

    NH2-C4-NH-Boc (compound 15) is a PROTAC linker belonging to the Alkyl/ether class. NH2-C4-NH-Boc can be used to synthesize a series of PROTAC molecules.

  • CMD178

    CMD178 is an important polypeptide that consistently reduces the expression of Foxp3 and STAT5 by inhibiting the IL-2/s IL-2Rα signaling pathway.